Disney parks lift earnings, ‘Avengers: Endgame’ streaming date announced
May 9, 2019
BlackRock pulls out of rescue bid for Italian bank Carige
May 9, 2019

Takeda sells dry eye drug to Novartis to help cut debt

Takeda Pharmaceutical Co Ltd agreed to sell its dry eye drug to Swiss drugmaker Novartis AG for $3.4 billion and potential milestone payments of up to $1.9 billion, in the first divestment since its takeover of Britain’s Shire.

Powered by WPeMatico